EMILY YANG: Open Payments
NPI 1356951941 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,826 in 60 payments from 16 companies in 2025. Trend: 2023 $1,579 · 2024 $1,597 · 2025 $1,826
Food & beverage: $1,826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $553 |
| Ardelyx, Inc. | 9 | $282 |
| HISTOSONICS, INC. | 1 | $189 |
| Janssen Biotech, Inc. | 2 | $173 |
| Aimmune Therapeutics, Inc. | 2 | $155 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $104 |
| Lilly USA, LLC | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| QOL Medical, LLC | 3 | $60 |
| Echosens North America, Inc. | 1 | $47 |
Products named: IBSRELA, LINZESS, TREMFYA, CREON, RINVOQ, ZENPEP, ISTURISA, OMVOH.
Industry payments across CA — which companies pay providers there.
